tizanidine

Generic: tizanidine

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name tizanidine
Generic Name tizanidine
Labeler a-s medication solutions
Dosage Form TABLET
Routes
ORAL
Active Ingredients

tizanidine hydrochloride 4 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-5767
Product ID 50090-5767_e68d46ad-efb1-4422-9320-154acf969626
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA091283
Listing Expiration 2027-12-31
Marketing Start 2013-04-01

Pharmacologic Class

Classes
adrenergic alpha2-agonists [moa] central alpha-2 adrenergic agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500905767
Hyphenated Format 50090-5767

Supplemental Identifiers

RxCUI
313413
UNII
B53E3NMY5C

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tizanidine (source: ndc)
Generic Name tizanidine (source: ndc)
Application Number ANDA091283 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 4 mg/1
source: ndc
Packaging
  • 120 TABLET in 1 BOTTLE (50090-5767-0)
  • 60 TABLET in 1 BOTTLE (50090-5767-2)
  • 15 TABLET in 1 BOTTLE (50090-5767-3)
  • 30 TABLET in 1 BOTTLE (50090-5767-4)
  • 90 TABLET in 1 BOTTLE (50090-5767-6)
  • 14 TABLET in 1 BOTTLE (50090-5767-7)
source: ndc

Packages (6)

50090-5767-0 120 TABLET in 1 BOTTLE (50090-5767-0) 50090-5767-2 60 TABLET in 1 BOTTLE (50090-5767-2) 50090-5767-3 15 TABLET in 1 BOTTLE (50090-5767-3) 50090-5767-4 30 TABLET in 1 BOTTLE (50090-5767-4) 50090-5767-6 90 TABLET in 1 BOTTLE (50090-5767-6) 50090-5767-7 14 TABLET in 1 BOTTLE (50090-5767-7)

Ingredients (1)

tizanidine hydrochloride (4 mg/1)

Linked Drug Pages (1)

Tizanidine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "e68d46ad-efb1-4422-9320-154acf969626", "openfda": {"unii": ["B53E3NMY5C"], "rxcui": ["313413"], "spl_set_id": ["308d2fdc-6136-4e75-95d3-342497add66c"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET in 1 BOTTLE (50090-5767-0)", "package_ndc": "50090-5767-0", "marketing_start_date": "20211004"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (50090-5767-2)", "package_ndc": "50090-5767-2", "marketing_start_date": "20211004"}, {"sample": false, "description": "15 TABLET in 1 BOTTLE (50090-5767-3)", "package_ndc": "50090-5767-3", "marketing_start_date": "20211004"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (50090-5767-4)", "package_ndc": "50090-5767-4", "marketing_start_date": "20211004"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (50090-5767-6)", "package_ndc": "50090-5767-6", "marketing_start_date": "20211004"}, {"sample": false, "description": "14 TABLET in 1 BOTTLE (50090-5767-7)", "package_ndc": "50090-5767-7", "marketing_start_date": "20211004"}], "brand_name": "Tizanidine", "product_id": "50090-5767_e68d46ad-efb1-4422-9320-154acf969626", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "50090-5767", "generic_name": "Tizanidine", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tizanidine", "active_ingredients": [{"name": "TIZANIDINE HYDROCHLORIDE", "strength": "4 mg/1"}], "application_number": "ANDA091283", "marketing_category": "ANDA", "marketing_start_date": "20130401", "listing_expiration_date": "20271231"}